NAT10 and acute myeloid leukemia: In an in vitro study, NAT10 inhibition—achieved through shRNA knockdown and pharmacological inhibitors—reduced cell proliferation, caused G1 cell cycle arrest, and increased apoptosis in AML cells (Table 2).